# A Clinical Study of KRN321 in Adult Subjects With Myelodysplastic Syndrome

> **NCT01497145** · PHASE2 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 45 (estimated)

## Conditions studied

- MDS

## Interventions

- **DRUG:** KRN321

## Key facts

- **NCT ID:** NCT01497145
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2015-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01497145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01497145, "A Clinical Study of KRN321 in Adult Subjects With Myelodysplastic Syndrome". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT01497145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*